A mechanic with confusion and right-sided weakness.

Autor: Edmond EC; Department of Neurosciences, Oxford University Hospitals NHS Foundation Trust, Oxford, UK eedmond@gmail.com.; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Haighton C; Department of Neurology, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK., Botcherby EJ; Department of Neurology, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK., Thompson A; Department of Neurosciences, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, UK., Kueker W; Department of Neurosciences, Oxford University Hospitals NHS Foundation Trust, Oxford, UK., Butterworth R; Department of Neurosciences, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Department of Neurology, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK., Kousin-Ezewu O; Department of Neurology, Milton Keynes University Hospital NHS Foundation Trust, Milton Keynes, UK.

Publikováno v: Practical neurology [Pract Neurol] 2021 Feb 23. Date of Electronic Publication: 2021 Feb 23.

Keratinocyte growth factor impairs human thymic recovery from lymphopenia.

Autor: Coles AJ; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Azzopardi L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Kousin-Ezewu O; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Mullay HK; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Thompson SA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Jarvis L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Davies J; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Howlett S; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Rainbow D; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Babar J; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Sadler TJ; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Brown JWL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Needham E; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., May K; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Georgieva ZG; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Handel AE; Nuffield Department of Clinical Neurosciences and., Maio S; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Deadman M; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Rota I; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Holländer G; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Dawson S; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Medical Research Council (MRC) Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom., Jayne D; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Seggewiss-Bernhardt R; University Hospital of Würzburg, Würzburg, Germany.; Department of Hematology/Oncology, Soziastiftung Bamberg, Bamberg, Germany., Douek DC; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Isaacs JD; Institute of Cellular Medicine, Newcastle University, and Musculoskeletal Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Jones JL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Publikováno v: JCI insight [JCI Insight] 2019 May 07; Vol. 5. Date of Electronic Publication: 2019 May 07.

Anti-IL-7 receptor α monoclonal antibody (GSK2618960) in healthy subjects - a randomized, double-blind, placebo-controlled study.

Autor: Ellis J; GlaxoSmithKline, Stevenage, Herts, UK., van Maurik A; GlaxoSmithKline, Stevenage, Herts, UK., Fortunato L; GlaxoSmithKline, Stevenage, Herts, UK., Gisbert S; GlaxoSmithKline, Uxbridge, Middlesex, UK., Chen K; GlaxoSmithKline, King of Prussia, PA, USA., Schwartz A; GlaxoSmithKline, King of Prussia, PA, USA., McHugh S; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK., Want A; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK., Santos Franco S; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK., Oliveira JJ; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK., Price J; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK., Coles A; Clinical Neurosciences, University of Cambridge, UK., Brown K; GlaxoSmithKline, Stevenage, Herts, UK., Su D; GlaxoSmithKline, Shanghai, China.; Shanghai Henlius Biotech, Inc., Shanghai, China., Craigen JL; GlaxoSmithKline, Stevenage, Herts, UK.; Crescendo Biologics, Cambridge, UK., Yang J; GlaxoSmithKline, Shanghai, China.; Mosim Co. Ltd, Shanghai, China., Brett S; GlaxoSmithKline, Stevenage, Herts, UK., Davis B; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK., Cheriyan J; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK.; Cambridge University Hospitals, NHS Foundation Trust, Cambridge, UK., Kousin-Ezewu O; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK.; Clinical Neurosciences, University of Cambridge, UK., Gray F; Indivior, Slough, Berks, UK., Thompson PW; Mission Therapeutics Ltd, Babraham Research Campus, Cambridge, UK., Fernando D; GlaxoSmithKline R&D, Addenbrooke's Centre for Clinical Investigation, Cambridge, UK.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2019 Feb; Vol. 85 (2), pp. 304-315. Date of Electronic Publication: 2018 Dec 03.

Accelerated lymphocyte recovery after alemtuzumab does not predict multiple sclerosis activity.

Autor: Kousin-Ezewu O; From the Department of Clinical Neurosciences (O.K.-E., L.A., O.T., A. Compston, A. Coles, J.J.) and the Centre for Applied Medical Statistics, Department of Public Health and Primary Care (R.A.P.), University of Cambridge, UK., Azzopardi L; From the Department of Clinical Neurosciences (O.K.-E., L.A., O.T., A. Compston, A. Coles, J.J.) and the Centre for Applied Medical Statistics, Department of Public Health and Primary Care (R.A.P.), University of Cambridge, UK., Parker RA; From the Department of Clinical Neurosciences (O.K.-E., L.A., O.T., A. Compston, A. Coles, J.J.) and the Centre for Applied Medical Statistics, Department of Public Health and Primary Care (R.A.P.), University of Cambridge, UK., Tuohy O; From the Department of Clinical Neurosciences (O.K.-E., L.A., O.T., A. Compston, A. Coles, J.J.) and the Centre for Applied Medical Statistics, Department of Public Health and Primary Care (R.A.P.), University of Cambridge, UK., Compston A; From the Department of Clinical Neurosciences (O.K.-E., L.A., O.T., A. Compston, A. Coles, J.J.) and the Centre for Applied Medical Statistics, Department of Public Health and Primary Care (R.A.P.), University of Cambridge, UK., Coles A; From the Department of Clinical Neurosciences (O.K.-E., L.A., O.T., A. Compston, A. Coles, J.J.) and the Centre for Applied Medical Statistics, Department of Public Health and Primary Care (R.A.P.), University of Cambridge, UK., Jones J; From the Department of Clinical Neurosciences (O.K.-E., L.A., O.T., A. Compston, A. Coles, J.J.) and the Centre for Applied Medical Statistics, Department of Public Health and Primary Care (R.A.P.), University of Cambridge, UK. jls53@medschl.cam.ac.uk.

Publikováno v: Neurology [Neurology] 2014 Jun 17; Vol. 82 (24), pp. 2158-64. Date of Electronic Publication: 2014 May 16.

Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy.

Autor: Hecker, Michael¹ (AUTHOR) michael.hecker@rocketmail.com, Fitzner, Brit¹ (AUTHOR), Boxberger, Nina¹ (AUTHOR), Putscher, Elena¹ (AUTHOR), Engelmann, Robby² (AUTHOR), Bergmann, Wendy³ (AUTHOR), Müller, Michael³ (AUTHOR), Ludwig-Portugall, Isis⁴ (AUTHOR), Schwartz, Margit¹ (AUTHOR), Meister, Stefanie¹ (AUTHOR), Dudesek, Ales¹ (AUTHOR), Winkelmann, Alexander¹ (AUTHOR), Koczan, Dirk⁵ (AUTHOR), Zettl, Uwe Klaus¹ (AUTHOR)

Publikováno v: Journal of Neuroinflammation. 8/2/2023, Vol. 20 Issue 1, p1-18. 18p.